C

Centrum Medyczne Enel Med SA
WSE:ENE

Watchlist Manager
Centrum Medyczne Enel Med SA
WSE:ENE
Watchlist
Price: 18 PLN 4.65%
Market Cap: 509m PLN

Intrinsic Value

The intrinsic value of one ENE stock under the Base Case scenario is 26.45 PLN. Compared to the current market price of 18 PLN, Centrum Medyczne Enel Med SA is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENE Intrinsic Value
26.45 PLN
Undervaluation 32%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Centrum Medyczne Enel Med SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about ENE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ENE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Centrum Medyczne Enel Med SA.

Explain Valuation
Compare ENE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ENE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Centrum Medyczne Enel Med SA

Current Assets 88.8m
Cash & Short-Term Investments 34.3m
Receivables 50m
Other Current Assets 4.5m
Non-Current Assets 503.1m
Long-Term Investments 6k
PP&E 471.2m
Intangibles 20.1m
Other Non-Current Assets 11.8m
Current Liabilities 150.9m
Accounts Payable 91.3m
Accrued Liabilities 2.4m
Other Current Liabilities 57.2m
Non-Current Liabilities 257.3m
Long-Term Debt 253.5m
Other Non-Current Liabilities 3.8m
Efficiency

Free Cash Flow Analysis
Centrum Medyczne Enel Med SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Centrum Medyczne Enel Med SA

Revenue
820.6m PLN
Cost of Revenue
-746.1m PLN
Gross Profit
74.5m PLN
Operating Expenses
-50m PLN
Operating Income
24.4m PLN
Other Expenses
-14m PLN
Net Income
10.4m PLN
Fundamental Scores

ENE Profitability Score
Profitability Due Diligence

Centrum Medyczne Enel Med SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Operating Margin is Increasing
Gross Margin is Increasing
46/100
Profitability
Score

Centrum Medyczne Enel Med SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ENE Solvency Score
Solvency Due Diligence

Centrum Medyczne Enel Med SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Average Altman Z-Score
Short-Term Solvency
31/100
Solvency
Score

Centrum Medyczne Enel Med SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENE Price Targets Summary
Centrum Medyczne Enel Med SA

There are no price targets for ENE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ENE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ENE stock?

The intrinsic value of one ENE stock under the Base Case scenario is 26.45 PLN.

Is ENE stock undervalued or overvalued?

Compared to the current market price of 18 PLN, Centrum Medyczne Enel Med SA is Undervalued by 32%.

Back to Top